↓ Skip to main content

Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan

Overview of attention for article published in PLOS ONE, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs
1 blog
twitter
11 X users
patent
115 patents
wikipedia
1 Wikipedia page
reddit
2 Redditors

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
72 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
Published in
PLOS ONE, February 2014
DOI 10.1371/journal.pone.0089985
Pubmed ID
Authors

Linda Nguyen, Matthew J. Robson, Jason R. Healy, Anna L. Scandinaro, Rae R. Matsumoto

Abstract

Dextromethorphan is an antitussive with a high margin of safety that has been hypothesized to display rapid-acting antidepressant activity based on pharmacodynamic similarities to the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine. In addition to binding to NMDA receptors, dextromethorphan binds to sigma-1 (σ1) receptors, which are believed to be protein targets for a potential new class of antidepressant medications. The purpose of this study was to determine whether dextromethorphan elicits antidepressant-like effects and the involvement of σ1 receptors in mediating its antidepressant-like actions. The antidepressant-like effects of dextromethorphan were assessed in male, Swiss Webster mice using the forced swim test. Next, σ1 receptor antagonists (BD1063 and BD1047) were evaluated in conjunction with dextromethorphan to determine the involvement of σ receptors in its antidepressant-like effects. Quinidine, a cytochrome P450 (CYP) 2D6 inhibitor, was also evaluated in conjunction with dextromethorphan to increase the bioavailability of dextromethorphan and reduce exposure to additional metabolites. Finally, saturation binding assays were performed to assess the manner in which dextromethorphan interacts at the σ1 receptor. Our results revealed dextromethorphan displays antidepressant-like effects in the forced swim test that can be attenuated by pretreatment with σ1 receptor antagonists, with BD1063 causing a shift to the right in the dextromethorphan dose response curve. Concomitant administration of quinidine potentiated the antidepressant-like effects of dextromethorphan. Saturation binding assays revealed that a Ki concentration of dextromethorphan reduces both the Kd and the Bmax of [(3)H](+)-pentazocine binding to σ1 receptors. Taken together, these data suggest that dextromethorphan exerts some of its antidepressant actions through σ1 receptors.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Czechia 1 1%
Unknown 70 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 17%
Other 9 13%
Student > Bachelor 8 11%
Student > Master 8 11%
Student > Ph. D. Student 6 8%
Other 15 21%
Unknown 14 19%
Readers by discipline Count As %
Medicine and Dentistry 15 21%
Pharmacology, Toxicology and Pharmaceutical Science 9 13%
Agricultural and Biological Sciences 9 13%
Neuroscience 7 10%
Biochemistry, Genetics and Molecular Biology 4 6%
Other 11 15%
Unknown 17 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#1,729,130
of 25,483,400 outputs
Outputs from PLOS ONE
#21,205
of 222,090 outputs
Outputs of similar age
#17,038
of 235,829 outputs
Outputs of similar age from PLOS ONE
#660
of 5,925 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 222,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,829 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 5,925 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.